Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Perkins

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The American Journal of the Medical Sciences|November 20, 1997
Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantationD P Agaliotis, O F Ballester, T Mattox, et al.
Seminars in Oncology|May 13, 1998
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancerK K Fields, G J Elfenbein, J B Perkins, et al.
Hematological Oncology|January 1, 1992
Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphomaK K Fields, G J Elfenbein, R A Saleh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profileK K Fields, G J Elfenbein, H M Lazarus, et al.
Bone Marrow Transplantation|January 31, 1998
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiencyO F Ballester, R Tummala, W E Janssen, et al.
Bone Marrow Transplantation|September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remissionG Kunter, J B Perkins, J Pidala, et al.
Bone Marrow Transplantation|August 25, 2015
Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experienceR Nelson, J F Shapiro, J B Perkins, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The American Journal of the Medical Sciences|November 20, 1997
Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantationD P Agaliotis, O F Ballester, T Mattox, et al.
Seminars in Oncology|May 13, 1998
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancerK K Fields, G J Elfenbein, J B Perkins, et al.
Hematological Oncology|January 1, 1992
Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphomaK K Fields, G J Elfenbein, R A Saleh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profileK K Fields, G J Elfenbein, H M Lazarus, et al.
Bone Marrow Transplantation|January 31, 1998
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiencyO F Ballester, R Tummala, W E Janssen, et al.
Bone Marrow Transplantation|September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remissionG Kunter, J B Perkins, J Pidala, et al.
Bone Marrow Transplantation|August 25, 2015
Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experienceR Nelson, J F Shapiro, J B Perkins, et al.
Pageof 4